NewAmsterdam Pharma Company N.V. (NAMSW)

SEC filing

NewAmsterdam Pharma Company N.V.

NAMSW · CIK 1936258

4 · Sep 15, 2026 · Director, Chief Executive Officer Davidson Michael H. bought 10K shares at $22.65/share ($226.5K)

Director, Chief Executive Officer Davidson Michael H. bought 10K shares at $22.65/share ($226.5K)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.